Matches in Wikidata for { <http://www.wikidata.org/entity/Q64171555> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64171555 description "clinical trial" @default.
- Q64171555 description "ensayu clínicu" @default.
- Q64171555 description "klinisch onderzoek" @default.
- Q64171555 description "клінічне випробування" @default.
- Q64171555 name "Study of EDO-S101, A First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies" @default.
- Q64171555 type Item @default.
- Q64171555 label "Study of EDO-S101, A First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies" @default.
- Q64171555 prefLabel "Study of EDO-S101, A First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies" @default.
- Q64171555 P1050 Q64171555-549C43F4-B51E-44E6-AE43-E9E210D1CAA7 @default.
- Q64171555 P1050 Q64171555-E40F0794-978F-47DA-BF95-0AA87310F0B9 @default.
- Q64171555 P1132 Q64171555-13315C36-6B9C-4AD4-A320-90F52262AD75 @default.
- Q64171555 P1476 Q64171555-0EA919B0-FD0C-4350-B713-3638D7064CBF @default.
- Q64171555 P17 Q64171555-160F283A-F630-405F-878F-FEBF1E96216E @default.
- Q64171555 P17 Q64171555-57C4D9E3-6260-49AF-A97B-89B9579A62CE @default.
- Q64171555 P17 Q64171555-7E5D2C6D-8FFD-4F92-907C-45568417A7C3 @default.
- Q64171555 P17 Q64171555-86CD167B-9FB3-4BBA-8F8E-75732CE8AE62 @default.
- Q64171555 P17 Q64171555-B3EF9D53-0AFB-4E53-9087-C3E16D4CD5B2 @default.
- Q64171555 P17 Q64171555-FB87C404-D631-402E-9F22-6DCBE36ED8F2 @default.
- Q64171555 P2899 Q64171555-99057EB3-992D-4EAF-8641-09CFA0EE4ADD @default.
- Q64171555 P3098 Q64171555-119DDE30-C4AC-45DB-8A05-A2E152C01A91 @default.
- Q64171555 P31 Q64171555-F13432BD-4D55-4C68-968F-77D0922343AF @default.
- Q64171555 P580 Q64171555-359CDA88-2774-44F9-9670-20DD0143FAA5 @default.
- Q64171555 P582 Q64171555-CC4C254B-2288-46A9-A7BC-A8263EB4E4E5 @default.
- Q64171555 P6099 Q64171555-93A9A74D-2427-4502-985A-8A3E70905CA8 @default.
- Q64171555 P6153 Q64171555-5B307E1C-63F9-439B-ABAC-947BAF894C3C @default.
- Q64171555 P6153 Q64171555-7AB7EC2D-E856-4007-A55E-B116E65A06A8 @default.
- Q64171555 P6153 Q64171555-A2BB9B4B-C5F1-4323-8DF3-B5555C7CA2F5 @default.
- Q64171555 P6153 Q64171555-CC9D5FE0-9A20-4CBE-8268-E4D9AF65042E @default.
- Q64171555 P6153 Q64171555-CF81DCB2-F6D1-44EF-A948-EC24F721345E @default.
- Q64171555 P6153 Q64171555-FDB1F7C9-01AC-4410-8987-6BEE2727C611 @default.
- Q64171555 P8363 Q64171555-6054444F-D8B8-4AC7-8A68-818FE160A886 @default.
- Q64171555 P921 Q64171555-4CC29583-7433-470C-98D1-2DD0217D1B99 @default.
- Q64171555 P921 Q64171555-94722EBA-4BE0-4C8E-8552-0FCBCC64452D @default.
- Q64171555 P1050 Q208414 @default.
- Q64171555 P1050 Q467635 @default.
- Q64171555 P1132 "+111" @default.
- Q64171555 P1476 "A Phase 1 Study to Investigate the Safety, Pharmacokinetic Profiles and the Efficacy of EDO-S101, a First-in-Class Alkylating Histone Deacetylase Inhibition (HDACi) Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies" @default.
- Q64171555 P17 Q142 @default.
- Q64171555 P17 Q29 @default.
- Q64171555 P17 Q30 @default.
- Q64171555 P17 Q38 @default.
- Q64171555 P17 Q39 @default.
- Q64171555 P17 Q55 @default.
- Q64171555 P2899 "+18" @default.
- Q64171555 P3098 "NCT02576496" @default.
- Q64171555 P31 Q30612 @default.
- Q64171555 P580 "2016-03-01T00:00:00Z" @default.
- Q64171555 P582 "2020-12-01T00:00:00Z" @default.
- Q64171555 P6099 Q5452194 @default.
- Q64171555 P6153 Q1065414 @default.
- Q64171555 P6153 Q1130172 @default.
- Q64171555 P6153 Q2415975 @default.
- Q64171555 P6153 Q2945675 @default.
- Q64171555 P6153 Q633529 @default.
- Q64171555 P6153 Q87762406 @default.
- Q64171555 P8363 Q78089383 @default.
- Q64171555 P921 Q18557991 @default.
- Q64171555 P921 Q1891209 @default.